We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Artificial Cell Demonstrates Dynamic Gene Regulation

By LabMedica International staff writers
Posted on 14 Dec 2014
Print article
A team of Israeli scientists created an "artificial cell" on a silicon chip that is capable of metabolism, programmable protein synthesis, and molecular signaling.

The assembly of artificial cells capable of executing synthetic DNA programs has been an important goal for basic research and biotechnology. In a step toward reaching this goal, investigators at the Weizmann Institute of Science (Rehovot, Israel) assembled artificial cells based on two-dimensional DNA compartments fabricated in silicon. Each compartment contained strands of DNA together with an extract of E. coli bacteria lacking its own DNA. Metabolism was maintained by continuous diffusion of nutrients and products through a thin capillary, connecting protein synthesis in the DNA compartments with the environment.

These unique biochips were based on a new molecule, that the investigators called "Daisy," which formed a photolitographic monolayer on glass. Using photolithography, they were able to immobilize any biomolecule on Daisy-coated surfaces with controlled density at sub-micron resolution. Specifically, they developed a methodology for immobilizing whole genes, thousands of base-pairs long, at local gene density similar to that in a bacterium cell. This DNA/surface interface provided means to investigate gene expression under conditions of crowding and confinement. Additionally, they demonstrated a simple two-stage gene circuit and the integration of such systems in microfluidic devices.

A paper published in the August 15, 2014, issue of the journal Science described the programming of protein expression cycles, autoregulated protein levels, and a signaling expression gradient in an array of interconnected compartments at the scale of an embryo. Gene expression in the DNA compartment revealed a rich, dynamic system that was controlled by geometry, offering a means for studying biological networks outside a living cell.

Senior author Dr. Roy Bar-Ziv, professor of materials and interfaces at the Weizmann Institute of Science, said, “The idea to mimic a living cell is a longstanding dream shared by many. If we can build a primitive model of something so complex, we can possibly understand the dynamics of protein synthesis better. Our on-chip "genome" is in the form of a DNA brush with thousands of DNA strands attached at one of their ends to the surface like the hairs of a toothbrush. In principle, we can encode thousands of different genes. In practice, we demonstrated simple gene networks that are composed with just two genes hooked up to each other to create feedback. We will never be able to reproduce a complex cell that has evolved for millions of years. But we can design a primitive system that mimics the dynamics of all cells, synthesizing the appropriate enzymes and proteins to digest the food source and shutting down those not needed anymore.”

“Our major achievement is having localization of protein synthesis on the surface, and turning on and off genes dynamically,” said Dr. Bar-Ziv. “That is important, because in our own cells there is always a dynamic regulation going on between protein synthesis and gene shut-off. Without a mechanism to regulate that in artificial cells, you cannot have dynamic behavior such as oscillation. By embedding the appropriate genes, we were able to demonstrate for the first time dynamic modes approaching synthesis.”

Related Links:
Weizmann Institute of Science


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Cancer Mutation Profiling Liquid Kit
OncoScreen Plus

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.